Navigation Links
Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011
Date:8/30/2011

YORK, Pa., Aug. 30, 2011 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced its preliminary financial results for the fourth quarter and fiscal year ended June 30, 2011.

Corporate Highlights:

  • Completed construction of new global headquarters and commercial production facility in York, PA and successfully relocated entire staff (December 2010)
  • Appointed Dr. Ramin Mojdeh as Chief Operating Officer (February 2011), and continued to expanded management team to support business growth related to the ramp up of Unifill sales and marketing program, and commercialization of other pipeline devices (July 2011)
  • Initiated business realignment plan to improve cash flow and extend cash reserves by over $12 million during calendar year 2011 (April 2011)
  • Further strengthened balance sheet with $10 million equipment financing agreement through Varilease Finance, Inc. (August 2011)

  • Device Portfolio Highlights:

  • Secured U.S. FDA 510K Clearance for Unitract™ 1mL TB Syringe (September 2010).
  • Commenced sales of Unitract™ 1mL syringes in U.S. (November 2010)
  • Commenced initial production of Unifill® prefilled syringes at new global headquarters and manufacturing facility (March 2011)
  • Successfully completed the industrialization of the Unifill syringe (June 2011)
  • Secured initial agreement with a leading global pharmaceutical company for the development of a pipeline product in conjunction with a pipeline biologic drug for targeted organ delivery. The device was selected for clinical trials scheduled to commence from calendar Q4 2011 to Q1 2012. (June 2011)
  • Commenced initial supply of the Unifill syringe to Sanofi (July 2011)
  • Commenced initial sales of Unifill syringe to a U.S.-based global pharmaceutical company (Jul
    '/>"/>

  • SOURCE Unilife Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. Unilife Develops Proprietary Range of Auto-Injectors for Patient Self-Administration of Injectable Drugs
    2. Unilife Develops Unifill® EZMix Multiple-Chamber Prefilled Syringes
    3. Unilife Signs $10 Million Equipment Financing Agreement
    4. Unilife Expands Management Team to Support Business Growth
    5. Unilife Starts Unifill Syringe Sales to Another Pharmaceutical Customer
    6. Unilife Successfully Completes Industrialization of Unifill Syringe
    7. Unilife Hosts White House Business Council Meeting
    8. Unilife to Present at the 2011 Jefferies Global Healthcare Conference in New York City
    9. Unilife to Present at the 2011 UBS Global Specialty Pharmaceuticals Conference in London
    10. Unilife Announces Financial Results for the Third Quarter of Fiscal 2011
    11. Unilife Corporation to Announce Financial Results for Fiscal 2011 Third Quarter on Monday, May 16, 2011
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2015)... , Aug. 27, 2015  Eli Lilly and ... Stanley Global Healthcare Conference on Thursday, September 17, 2015. ... president of Lilly Oncology and Richard Gaynor , ... affairs for Lilly Oncology, will participate in a fireside ... A live audio webcast will be available on ...
    (Date:8/27/2015)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), the ... and patent-protected processes to develop and market advanced ... Orthopedic, Spine, Sports Medicine, Ophthalmic and Dental sectors ... inaccuracies in the press release issued by the ... from the Patent Trial and Appeal Board ("PTAB"). ...
    (Date:8/27/2015)... 2015  Hill-Rom Holdings, Inc., (NYSE: HRC ) ... the Morgan Stanley Global Healthcare Conference on September 16, ... invited to listen to the live discussion via the ... at https://cc.talkpoint.com/morg007/091615a_ae/?entity=49_UCJPU8N . A recorded replay ... the conclusion of the live event and accessible via ...
    Breaking Medicine Technology:Lilly to Participate in Morgan Stanley Global Healthcare Conference 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 2MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 3MiMedx Corrects Inaccuracies In MTF Press Release Regarding The Recent Rulings From The Patent Trial And Appeal Board 4
    ... Significance, FRAZER, Pa., May 01, 2007 /PRNewswire-FirstCall/ ... presented today at the 59th Annual,Meeting of ... highlights,data demonstrating that FENTORA(R) (fentanyl buccal tablet) ... pain in patients,with neuropathic pain who are ...
    ... Inc. (NYSE:DNA),and Biogen Idec, Inc. (Nasdaq:BIIB) announced ... study of Rituxan(R) (rituximab) in,patients with relapsing-remitting ... American Academy of Neurology annual meeting,held in ... targets and,selectively depletes CD20-positive B-cells., "There remains ...
    Cached Medicine Technology:Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 2Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 3Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 4Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 5Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 6Cephalon Presents Positive Results for Fentora in Breakthrough Pain,Associated with Neuropathic Conditions 7Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 2Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 3Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 4Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 5Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple,Sclerosis Presented at the American Academy of Neurology 6
    (Date:8/28/2015)... , ... August 28, 2015 , ... ... announce its collaboration with coffee connoisseur and Emmy-nominated actress, Sofia Vergara, and unveil ... features revolutionary Thermal Flavor Extraction™ technology, which delivers a variety of sizes and ...
    (Date:8/28/2015)... ... August 28, 2015 , ... ... Dual Eligibles Database have added comprehensive information on two new duals programs: ... a December 2015 launch; and Idaho’s partnership to revamp Blue Cross of ...
    (Date:8/28/2015)... Louis, MO (PRWEB) , ... August 28, 2015 ... ... in testosterone lawsuits now consolidated as MDL 2545, Testosterone Replacement Therapy ... of a cap on the number of custodial files the PSC may receive ...
    (Date:8/28/2015)... ... ... Super-Sod launched their new website this summer. The new user-friendly ... the responsive web design. Website users will now have an improved browsing experience on ... sod, sign-up for the monthly turf-tips email, and find a local Super-Sod store all ...
    (Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... approach to medicine through health promotion and disease prevention, improving a patient’s quality ... prevalent diseases in the community, including heart disease, cancer, diabetes, HIV/AIDS, STDs, and ...
    Breaking Medicine News(10 mins):Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3Health News:AIS Duals Database: August Update Finds Two New Duals Programs in Rhode Island and Idaho 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4Health News:Health Clinic Opening and Public Art Unveiling 2
    ... Key West Spa ... ... award-winning Jala Spa at Hyatt,s Key West Resort is inviting couples to slip ... the Beach" spa treatment. , , , , ,The reflexology-inspired experience at the West ...
    ... ... "The View" hits radio on July 6th. , ... Atlanta, GA (PRWEB) July 7, 2010 -- Sponsored ... and Southeast this summer for Ryan Hamner Presents: “Hear the Heart” Summer Tour 2010. ...
    ... ... interactive solutions to include SMS / Text Messaging. , ... Buffalo, NY (Vocus) July 7, 2010 -- IVR Technology Group (ITG) ... / Text Messaging . With this new addition to their product line up, they ...
    ... Obesity ... creator of the Zone Diet. , ... Boston (Vocus) July 6, 2010 -- Appearing on The Mel Robbins Show , ... bestselling author of The Zone, detailed the underlying causes of America’s obesity crisis and talked ...
    ... length of leukocyte telomeres chromosome markers of biological aging ... death from cancer, according to a study in the July ... type of blood cell. Telomeres are a structure at ... stability of the chromosome. Genetic factors and environmental stressors can ...
    ... shown that cognitive therapy is an effective treatment for ... therapists, training and expertise plays in making treatment successful. ... more symptom improvement when their therapists more competently follow ... also suggests therapist competence may be a particularly important ...
    Cached Medicine News:Health News:Relax, Recharge And Reflex This Summer At A Leading Key West Resort 2Health News:Ryan Hamner's Free Hear The Heart Tour Sweeping The South Four-Time Cancer Survivor, Sings Hope To Others 2Health News:IVR Technology Group Announces MobileMarketing123.com 2Health News:Zone Diet Creator Dr. Sears Discusses Obesity Causes and Solutions on Mel Robbins Radio Show 2Health News:Length of biological marker associated with risk of cancer 2Health News:Therapist competence matters -- and more for some patients than others 2Health News:Therapist competence matters -- and more for some patients than others 3
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: